Key Documents
Eliza Chakravarty
Academic Appointments
- Assistant Professor - Med Center Line, Medicine - Immunology & Rheumatology
Contact Information
-
Clinical Offices
Immunology & Rheumatology Clinic 300 Pasteur Dr A175 MC 5309 Stanford, CA 94305 Tel Work (650) 723-6961 Fax (650) 725-8418
Professional Snapshot
Clinical Focus
- Immunology and Rheumatology
- Rheumatology
Professional Education
| Board Certification: | Rheumatology, American Board of Internal Medicine (2003) |
| Fellowship: | SUMC - Graduate Medical Education, CA (2003) |
| Board Certification: | Internal Medicine, American Board of Internal Medicine (2000) |
| Residency: | Santa Clara Valley Medical Center, CA USA (2000) |
| Internship: | Santa Clara Valley Medical Center, CA USA (1998) |
Postdoctoral Advisees
Industry Relationships
Stanford is committed to ethical and transparent interactions with our industry partners. It is our policy to disclose payments of $5,000 or more, equity valued at $5,000 or more in a publicly traded company, or any equity in a privately held company, to physicians and scientists employed by Stanford University from companies or other commercial entities with which they interact as part of their professional activities. View Full Information
| Consulting: | Genentech |
Scientific Focus
Current Research Interests
Research interests include clinical epidemiology, translational studies, and clinical trials. Areas of interest include systemic lupus erythematosus, scleroderma, rheumatoid arthritis, connective tissue diseases, and relationships between autoimmune diseases and pregnancy.
Clinical Trials
- A Study to Evaluate the Safety and Efficacy of Abatacept in Patients With Diffuse Systemic Sclerosis (Scleroderma) Recruiting
- Safety and Efficacy of Abatacept for Scleroderma Recruiting
- Imatinib in Systemic Sclerosis Recruiting
- A Study to Evaluate the Efficacy and Safety of Rituximab in Patients With Severe Systemic Lupus Erythematosus (SLE) No longer recruiting
Publications
- Giant cell myocarditis: a rare cardiovascular manifestation in a patient with systemic lupus erythematosus. Lupus. 2005; (2): 166-9
- Associations between rheumatoid arthritis and malignancy. Rheum Dis Clin North Am. 2004; (2): 271-84, vi
- A randomized, controlled trial of interferon-beta-1a (Avonex(R)) in patients with rheumatoid arthritis: a pilot study [ISRCTN03626626]. Arthritis Res Ther. 2004; (1): R73-R77
- The use of disease modifying antirheumatic drugs in women with rheumatoid arthritis of childbearing age: a survey of practice patterns and pregnancy outcomes. J Rheumatol. 2003; (2): 241-6
- Rheumatic syndromes associated with malignancy. Curr Opin Rheumatol. 2003; (1): 35-43
Help